Fas receptor and neuronal cell death after spinal cord ischemia
Détails
ID Serval
serval:BIB_FFDA57BA7A24
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Fas receptor and neuronal cell death after spinal cord ischemia
Périodique
Journal of Neuroscience
ISSN
0270-6474 (Print)
Statut éditorial
Publié
Date de publication
09/2000
Peer-reviewed
Oui
Volume
20
Numéro
18
Pages
6879-87
Notes
Journal Article Research Support, U.S. Gov't, P.H.S. --- Old month value: Sep 15
Résumé
Cell death from spinal cord injury is mediated in part by apoptotic mechanisms involving downstream caspases (e.g., caspase-3). Upstream mechanisms may involve other caspases such as procaspase-8, a 55 kDa apical caspase, which we found constitutively expressed within spinal cord neurons along with Fas. As early as 1.5 hr after transient ischemia, activated caspase-8 (p18) and caspase-8 mRNA appeared within neurons in intermediate gray matter and in medial ventral horn. We also detected evidence for an increase in death receptor complex by co-immunoprecipitation using Fas and anti-procaspase-8 after ischemia. At early time points, Fas and p18 were co-expressed within individual neurons, as were activated caspase-8 and caspase-3. Moreover, we detected p18 in cells before procaspase-3 cleavage product (p20), suggesting sequential activation. The appearance of cytosolic cytochrome c and gelsolin cleavage after ischemia was consistent with mitochondrial release and caspase-3 activation, respectively. Numerous terminal deoxynucleotidyl transferase-mediated DNA nick end-labeling-positive neurons contained p18 or p20 (65 and 80%, respectively), thereby supporting the idea that cells undergoing cell death contain both processed caspases. Our data are consistent with the idea that transient spinal cord ischemia induces the formation of a death-inducing signaling complex, which may participate in caspase-8 activation and sequential caspase-3 cleavage. Death receptors as well as downstream caspases may be useful therapeutic targets for limiting the death of cells in spinal cord.
Mots-clé
Animals Antigens, CD95/*metabolism *Apoptosis Caspase 3 Caspase 8 Caspase 9 Caspases/genetics/metabolism Cytochrome c Group/metabolism Disease Models, Animal Enzyme Precursors/genetics/metabolism Female Gelsolin/metabolism In Situ Nick-End Labeling Male Mice Mice, Inbred C57BL Neurons/*metabolism/pathology RNA, Messenger/biosynthesis Reperfusion Signal Transduction Spinal Cord/blood supply/*metabolism/pathology Spinal Cord Ischemia/*metabolism/pathology
Pubmed
Web of science
Création de la notice
25/01/2008 13:40
Dernière modification de la notice
20/08/2019 17:30